Header Logo

Connection

Bruce Fireman to United States

Back to Details
This is a "connection" page, showing publications Bruce Fireman has written about United States.
Bruce Fireman
Connection Strength
1.012
United States
  1. Waning 2-Dose and 3-Dose Effectiveness of mRNA Vaccines Against COVID-19-Associated Emergency Department and Urgent Care Encounters and Hospitalizations Among Adults During Periods of Delta and Omicron Variant Predominance - VISION Network, 10 States, August 2021-January 2022. MMWR Morb Mortal Wkly Rep. 2022 Feb 18; 71(7):255-263.
    View in: PubMed
    Score: 0.108
  2. Measles-containing vaccines and febrile seizures in children age 4 to 6 years. Pediatrics. 2012 May; 129(5):809-14.
    View in: PubMed
    Score: 0.054
  3. A protocol for active surveillance of acute myocardial infarction in association with the use of a new antidiabetic pharmaceutical agent. Pharmacoepidemiol Drug Saf. 2012 Jan; 21 Suppl 1:282-90.
    View in: PubMed
    Score: 0.053
  4. Impact of the use of heptavalent pneumococcal conjugate vaccine on disease epidemiology in children and adults. Vaccine. 2006 Apr 12; 24 Suppl 2:S2-79-80.
    View in: PubMed
    Score: 0.036
  5. Respiratory syncytial virus (RSV) vaccine effectiveness against RSV-associated hospitalisations and emergency department encounters among adults aged 60 years and older in the USA, October, 2023, to March, 2024: a test-negative design analysis. Lancet. 2024 Oct 19; 404(10462):1547-1559.
    View in: PubMed
    Score: 0.032
  6. Influenza Vaccine Effectiveness Against Influenza A-Associated Emergency Department, Urgent Care, and Hospitalization Encounters Among US Adults, 2022-2023. J Infect Dis. 2024 Jul 25; 230(1):141-151.
    View in: PubMed
    Score: 0.032
  7. Interim Effectiveness of Updated 2023-2024 (Monovalent XBB.1.5) COVID-19 Vaccines Against COVID-19-Associated Hospitalization Among Adults Aged =18 Years with Immunocompromising Conditions - VISION Network, September 2023-February 2024. MMWR Morb Mortal Wkly Rep. 2024 Mar 28; 73(12):271-276.
    View in: PubMed
    Score: 0.031
  8. Effectiveness of Monovalent and Bivalent mRNA Vaccines in Preventing COVID-19-Associated Emergency Department and Urgent Care Encounters Among Children Aged 6 Months-5 Years - VISION Network, United States, July 2022-June 2023. MMWR Morb Mortal Wkly Rep. 2023 Aug 18; 72(33):886-892.
    View in: PubMed
    Score: 0.030
  9. Primary health care teams. Opportunities and challenges in evaluation of service delivery innovations. J Ambul Care Manage. 2003 Jan-Mar; 26(1):22-35; discussion 36-8.
    View in: PubMed
    Score: 0.029
  10. Incidence of Myocarditis/Pericarditis Following mRNA COVID-19 Vaccination Among Children and Younger Adults in the United States. Ann Intern Med. 2022 12; 175(12):1169-1771.
    View in: PubMed
    Score: 0.028
  11. Estimation of COVID-19 mRNA Vaccine Effectiveness Against Medically Attended COVID-19 in Pregnancy During Periods of Delta and Omicron Variant Predominance in the United States. JAMA Netw Open. 2022 09 01; 5(9):e2233273.
    View in: PubMed
    Score: 0.028
  12. Incidence of Guillain-Barré Syndrome After COVID-19 Vaccination in the Vaccine Safety Datalink. JAMA Netw Open. 2022 04 01; 5(4):e228879.
    View in: PubMed
    Score: 0.027
  13. Effectiveness of COVID-19 Pfizer-BioNTech BNT162b2 mRNA Vaccination in Preventing COVID-19-Associated Emergency Department and Urgent Care Encounters and Hospitalizations Among Nonimmunocompromised Children and Adolescents Aged 5-17 Years - VISION Network, 10 States, April 2021-January 2022. MMWR Morb Mortal Wkly Rep. 2022 Mar 04; 71(9):352-358.
    View in: PubMed
    Score: 0.027
  14. Effectiveness of two-dose vaccination with mRNA COVID-19 vaccines against COVID-19-associated hospitalizations among immunocompromised adults-Nine States, January-September 2021. Am J Transplant. 2022 01; 22(1):306-314.
    View in: PubMed
    Score: 0.027
  15. Effectiveness of 2-Dose Vaccination with mRNA COVID-19 Vaccines Against COVID-19-Associated Hospitalizations Among Immunocompromised Adults - Nine States, January-September 2021. MMWR Morb Mortal Wkly Rep. 2021 Nov 05; 70(44):1553-1559.
    View in: PubMed
    Score: 0.026
  16. COVID-19 Vaccination Coverage Among Insured Persons Aged =16 Years, by Race/Ethnicity and Other Selected Characteristics - Eight Integrated Health Care Organizations, United States, December 14, 2020-May 15, 2021. MMWR Morb Mortal Wkly Rep. 2021 Jul 16; 70(28):985-990.
    View in: PubMed
    Score: 0.026
  17. Re: "Estimates of the annual number of clinically recognized pregnancies in the United States, 1981-1991". Am J Epidemiol. 2000 Aug 01; 152(3):287-9.
    View in: PubMed
    Score: 0.024
  18. Conducting prospective sequential surveillance in real-world dynamic distributed databases. Pharmacoepidemiol Drug Saf. 2020 10; 29(10):1331-1335.
    View in: PubMed
    Score: 0.024
  19. Cost of care for patients in cancer clinical trials. J Natl Cancer Inst. 2000 Jan 19; 92(2):136-42.
    View in: PubMed
    Score: 0.023
  20. Survival and treatment for colorectal cancer Medicare patients in two group/staff health maintenance organizations and the fee-for-service setting. Med Care Res Rev. 1999 Jun; 56(2):177-96.
    View in: PubMed
    Score: 0.022
  21. Adverse Selection into and within the Individual Health Insurance Market in California in 2014. Health Serv Res. 2018 10; 53(5):3750-3769.
    View in: PubMed
    Score: 0.021
  22. Prospective Postmarketing Surveillance of Acute Myocardial Infarction in New Users of Saxagliptin: A Population-Based Study. Diabetes Care. 2018 01; 41(1):39-48.
    View in: PubMed
    Score: 0.020
  23. Nearly One-Third Of Enrollees In California's Individual Market Missed Opportunities To Receive Financial Assistance. Health Aff (Millwood). 2017 01 01; 36(1):21-31.
    View in: PubMed
    Score: 0.019
  24. Risk of underlying chronic medical conditions for invasive pneumococcal disease in adults. Vaccine. 2016 08 05; 34(36):4293-7.
    View in: PubMed
    Score: 0.018
  25. Screening Mammography for Free: Impact of Eliminating Cost Sharing on Cancer Screening Rates. Health Serv Res. 2017 02; 52(1):191-206.
    View in: PubMed
    Score: 0.018
  26. The introduction of generic risperidone in Medicare Part D. Am J Manag Care. 2016 Jan; 22(1):41-8.
    View in: PubMed
    Score: 0.018
  27. Intravenous immune globulin and thromboembolic adverse events in patients with hematologic malignancy. Blood. 2016 Jan 14; 127(2):200-7.
    View in: PubMed
    Score: 0.017
  28. Safety of measles-containing vaccines in 1-year-old children. Pediatrics. 2015 Feb; 135(2):e321-9.
    View in: PubMed
    Score: 0.016
  29. Adenoma detection rate and risk of colorectal cancer and death. N Engl J Med. 2014 Apr 03; 370(14):1298-306.
    View in: PubMed
    Score: 0.016
  30. Do Medicare Advantage plans select enrollees in higher margin clinical categories? J Health Econ. 2013 Dec; 32(6):1278-88.
    View in: PubMed
    Score: 0.015
  31. Adverse clinical events among medicare beneficiaries using antipsychotic drugs: linking health insurance benefits and clinical needs. Med Care. 2013 Jul; 51(7):614-21.
    View in: PubMed
    Score: 0.015
  32. Comparative effectiveness of acellular versus whole-cell pertussis vaccines in teenagers. Pediatrics. 2013 Jun; 131(6):e1716-22.
    View in: PubMed
    Score: 0.015
  33. Risk of confirmed Guillain-Barre syndrome following receipt of monovalent inactivated influenza A (H1N1) and seasonal influenza vaccines in the Vaccine Safety Datalink Project, 2009-2010. Am J Epidemiol. 2012 Jun 01; 175(11):1100-9.
    View in: PubMed
    Score: 0.014
  34. Safety of zoster vaccine in adults from a large managed-care cohort: a Vaccine Safety Datalink study. J Intern Med. 2012 May; 271(5):510-20.
    View in: PubMed
    Score: 0.013
  35. H1N1 and seasonal influenza vaccine safety in the vaccine safety datalink project. Am J Prev Med. 2011 Aug; 41(2):121-8.
    View in: PubMed
    Score: 0.013
  36. Fixing flaws in Medicare drug coverage that prompt insurers to avoid low-income patients. Health Aff (Millwood). 2010 Dec; 29(12):2335-43.
    View in: PubMed
    Score: 0.012
  37. Validation of an algorithm for categorizing the severity of hospital emergency department visits. Med Care. 2010 Jan; 48(1):58-63.
    View in: PubMed
    Score: 0.012
  38. Distributing $800 billion: an early assessment of Medicare Part D risk adjustment. Health Aff (Millwood). 2009 Jan-Feb; 28(1):215-25.
    View in: PubMed
    Score: 0.011
  39. Medicare beneficiaries' knowledge of Part D prescription drug program benefits and responses to drug costs. JAMA. 2008 Apr 23; 299(16):1929-36.
    View in: PubMed
    Score: 0.010
  40. Cost-effectiveness of pneumococcal conjugate vaccine: evidence from the first 5 years of use in the United States incorporating herd effects. Pediatr Infect Dis J. 2006 Jun; 25(6):494-501.
    View in: PubMed
    Score: 0.009
  41. Unintended consequences of caps on Medicare drug benefits. N Engl J Med. 2006 Jun 01; 354(22):2349-59.
    View in: PubMed
    Score: 0.009
  42. Prostate cancer treatment and ten-year survival among group/staff HMO and fee-for-service Medicare patients. Health Serv Res. 1999 Jun; 34(2):525-46.
    View in: PubMed
    Score: 0.006
  43. Variation in practice for discretionary admissions. Impact on estimates of quality of hospital care. JAMA. 1994 May 18; 271(19):1493-8.
    View in: PubMed
    Score: 0.004
  44. Safety, immunogenicity, and efficacy in infancy of oligosaccharide conjugate Haemophilus influenzae type b vaccine in a United States population: possible implications for optimal use. J Infect Dis. 1992 Jun; 165 Suppl 1:S139-43.
    View in: PubMed
    Score: 0.003

© 2024 Kaiser Permanente